Half Year 2025 Exasol AG Earnings Call Transcript

Aug 12, 2025 / 10:59 AM GMT
Release Date Price: $3.6

Key Points

Positve
  • Exasol AG (XTER:EXL) reported a revenue increase of 10.8% year-over-year, reaching €21.5 million.
  • Net income grew significantly to €1.4 million from €0.3 million in the previous year.
  • The company achieved a strong focus on verticals, with 69% of ARR now coming from these sectors, nearing their target of 70% by year-end.
  • Exasol AG secured a major renewal and upsell deal with Finance Informatic, doubling their ARR with this customer.
  • The company's net liquidity increased to €22.2 million, providing strategic flexibility for future growth and investments.
Negative
  • Annual Recurring Revenue (ARR) declined by 2.8% year-over-year, primarily due to churn in non-focus sectors.
  • Two major retail customers moved to cloud setups, contributing to higher churn and ARR decline.
  • The company experienced a net ARR retention rate below 100%, driven by elevated churn in non-focus verticals.
  • Profitability in Q2 was lower than Q1, influenced by non-recurring hardware and service sales.
  • The decline in gross profit was partly due to lower research grants compared to the previous year, impacting overall profitability.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EXLn.DE - Exasol AG
Half Year 2025 Exasol AG Earnings Call
Aug 12, 2025 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day ladies and gentlemen, and a warm welcome to today's earnings call of the Exoagi following the publication of the first half year figures for the fiscal year 2025.

I am delighted to welcome AA Salt's CEO Jerk Davis and CFO Jan Dirk Heinrich, who will speak in a moment and guide us through the presentation and the results. After the presentation, we will move on to a Q&A session in which you will be allowed to place your questions directly to the management.

So I would say, let's jump straight into the numbers, Mr. Tevas, the stage is yours.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot